title: [Usefulness of neuron specific enolase in patients with head and neck malignant tumors].
abstract: The authors present results of evaluation of neuron specific enolase (NSE) in 146 persons. We analyzed a concentration of NSE in preliminary study and in monitoring depending on clinical advances of tumour, mass of primary tumour and metastases to lymph nodes. Neuron specific enolase was excluded because the number of positive results was the same both in the main and control group. Our results indicate that evaluation of NSE have not height value in monitoring patients with head and neck carcinoma.
authors.affiliation: Klinika Otolaryngologiczna Centralnego Szpitala Klinicznego Wojskowej Akademii Medycznej w Warszawie.
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Adamiak
authors.forename: Aleksander
authors.initials: A
authors.lastname: Ligeziński
authors.forename: Dariusz
authors.initials: D
authors.lastname: Jurkiewicz
authors.forename: Maciej
authors.initials: M
authors.lastname: Hermanowski
authors.forename: Maria
authors.initials: M
authors.lastname: Konieczna
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000201:enzymology* / Q000473:pathology / Q000556:secondary*; D005260:Female; D006258:Head and Neck Neoplasms / Q000201:enzymology* / Q000473:pathology; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010751:Phosphopyruvate Hydratase / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D010751:Phosphopyruvate Hydratase
vernacular_title: Przydatność oznaczeń neuronowej swoistej enolazy u chorych na nowotwory złośliwe głowy i szyi.